AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
J&J says AI is halving lead-generation time — and drug discovery is entering a new productivity race
Johnson & Johnson says artificial intelligence is cutting in half the time it takes to generate drug-development leads, a sign that AI is moving from promise to operational advantage in pharma. The key question now is whether faster lead generation translates into better molecules, better probabilities of success, and ultimately lower R&D costs.
J&J Says AI Is Halving Early Drug Lead Generation Time
Johnson & Johnson says AI has cut early drug lead generation time in half, a claim that could reshape expectations for discovery productivity. The key question now is whether speed gains translate into better molecules, not just faster ones.
J&J’s AI Interest Signals Drug Development Is Shifting From Experiment to Strategy
A RAPS roundup suggests Johnson & Johnson is exploring AI as a lever to cut drug development timelines, reflecting a broader pharma trend toward operationalizing AI. The article also notes improving UK biotech investment conditions, hinting at a more active market backdrop.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.